Search Results 461-470 of 38031 for Two-phase
In Part 2, the step-up dose identified in Part 1 will be used followed by ... This phase 1b trial is an open-label study designed to assess the safety ...
This is a phase 3, randomized, 2-arm, open-label, international trial evaluating alisertib compared with single-agent treatment, as selected by the investigator ...
Stage 1, 90 or above, Healthy kidney function. Stage 2, 60 to 89, Mild loss of kidney function. Stage 3a, 45 to 59, Mild to moderate loss of kidney function.
Phase 1-2 dose escalation randomized study in patients with intermediate or high risk myelodysplastic syndromes (MDS) or acute myelogenous leukemia (AML).
This is a Phase 1/2 open-label, multicenter study to evaluate the safety and tolerability and to explore the efficacy of gene therapy AMT-162 in ...
These therapies may reduce the amount of beta-amyloid formed in the brain. Research has shown that beta-amyloid is produced from a "parent protein" in two steps ...
Phase 2 (stage 1): To evaluate the activity of single-agent Isatuximab at different doses/schedules and to select dose and regimen to further evaluate the ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
The gracilis muscle transfer is the favored approach to restore a symmetric, spontaneous smile and usually is performed in two stages. The first stage ...
The primary purpose of this study for Step 2: To assess the anti-tumour activity of MEN1611 in combination with cetuximab in patients with PIK3CA mutated ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.